SCHEMBL4889770

SCHEMBL4889770

C=C(C#N)C(=O)OCCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.47
ALDH1A1 P00352 2/20 0.47
TSHR P16473 2/20 0.47
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
AKR1B10 O60218 2/20 0.45
AKR1B1 P15121 2/20 0.45
TP53 P04637 1/20 0.45
GLA P06280 1/20 0.45
CYP3A4 P08684 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HIF1A Q16665 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAOB P27338 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18924009 0.89 LMNA (0.50) ALDH1A1TSHRTDP1NPC1RAB9A
SCHEMBL20590698 0.84 ALDH1A1 (0.45) ALDH1A1TSHRRAB9AMMP2MMP12
SCHEMBL1603035 0.83 ALDH1A1 (0.50) HCAR2ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL14694691 0.80 HCAR2 (0.61) HCAR2ALDH1A1TSHRESR1ESR2
SCHEMBL4579700 0.80 TSHR (0.68) ALDH1A1TSHRTP53HIF1AHSD17B10
SCHEMBL8956817 0.80 ALDH1A1 (0.41) ALDH1A1TSHRTDP1L3MBTL1AKR1B10
SCHEMBL42893 0.78 HCAR2 (0.51) HCAR2ALDH1A1TSHRESR1ESR2
SCHEMBL11880691 0.78 HCAR2 (0.51) HCAR2ALDH1A1TSHRESR1ESR2
SCHEMBL3291000 0.78 LMNA (0.54) HCAR2ALDH1A1TSHRESR1ESR2
SCHEMBL1372604 0.78 HCAR2 (0.51) HCAR2ALDH1A1TSHRESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717744-A1 USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE Bostik SA (FR) 2026-04-01 EP claimed
US-20250215132-A1 TWO-PART CURABLE COMPOSITION BOSTIK SA (FR) 2025-07-03 US claimed
EP-4504844-A1 TWO-PART CURABLE COMPOSITION Bostik SA (FR) 2025-02-12 EP claimed
WO-2023194367-A1 TWO-PART CURABLE COMPOSITION BOSTIK SA (FR) 2023-10-12 WO claimed
EP-4257648-A1 TWO-PART CURABLE COMPOSITION Bostik SA (FR) 2023-10-11 EP claimed
EP-2852646-B1 AN ARTICLE COMPRISING A FILM ON A CARRIER OR RELEASE SUBSTRATE Henkel IP & Holding GmbH (DE) 2017-07-12 EP claimed
EP-2852645-B1 A CURABLE COMPOSITION COMPRISING CYANOACRYLATE MONOMERS HENKEL AG & CO KGAA (DE) 2016-04-13 EP claimed
US-20150107761-A1 ARTICLE COMPRISING A FILM ON A CARRIER OR RELEASE SUBSTRATE HENKEL AG & CO. KGAA (DE) 2015-04-23 US claimed
EP-2852645-A1 A CURABLE COMPOSITION COMPRISING CYANOACRYLATE MONOMERS Henkel AG & Co. KGaA (DE) 2015-04-01 EP claimed
EP-2852646-A1 AN ARTICLE COMPRISING A FILM ON A CARRIER OR RELEASE SUBSTRATE Henkel IP & Holding GmbH (DE) 2015-04-01 EP claimed
US-20150075709-A1 CURABLE COMPOSITION COMPRISING CYANOACRYLATE MONOMERS HENKEL AG & CO. KGAA (DE) 2015-03-19 US claimed
WO-2013174430-A1 AN ARTICLE COMPRISING A FILM ON A CARRIER OR RELEASE SUBSTRATE HENKEL AG & CO. KGAA (DE) 2013-11-28 WO claimed
WO-2013174431-A1 A CURABLE COMPOSITION COMPRISING CYANOACRYLATE MONOMERS HENKEL AG & CO. KGAA (DE) 2013-11-28 WO claimed
WO-2013174776-A1 AN ARTICLE COMPRISING A FILM ON A CARRIER OR RELEASE SUBSTRATE HENKEL AG & CO. KGAA (DE) 2013-11-28 WO claimed
CN-1239653-C Cyanoacrylate compositions, reaction products, methods of preparation and uses thereof LOCTITE R & D LTD (IE) 2006-02-01 CN claimed
CN-1487983-A Cyanoacrylate compositions curable to flexible polymeric materials ���̩��(R&D)���޹�˾ 2004-04-07 CN claimed
JP-6192202-A None JP disclosed
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2026-04-23 US disclosed
US-4724177-A Brushing cyanoacrylates: packaging and method RUSSO LIBBY J (US) 1988-02-09 US disclosed
US-4687827-A Brushing cyanoacrylates: packaging and method ROUSSEAU RESEARCH, INC. 1987-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES PARG, PUF60, PHOSPHO1 HCAR2 3113/4885ALDH1A1 3548/4885TSHR 2412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.